Andrew Adams

Co-Founder & Managing Partner at Oak HC/FT · Joined 2014

View Live Interactive Profile →

Biography

Andrew Adams is a co-founder and managing partner of Oak HC/FT, which he co-founded in 2014 to invest exclusively in healthcare and fintech entrepreneurs. His firm bio describes more than 25 years spent investing in healthcare companies, with roughly $10 billion in career assets under management, 35 exits and 6 IPOs. He currently sits on the boards of Akido, Artis BioSolutions, August Bioservices, Curana Health, DispatchHealth, Galileo, Infusion for Health, Marathon Health, Medical Home Network, Remodel Health, Reveleer, Rialtic, Thesis Care, Trovo Health and Unified Women's Healthcare, and remains involved with Noom and Precision Medicine Group. He began his career at Alex. Brown & Sons and holds a Bachelor of Arts degree from Princeton University.

Education

Previous Experience

Notable Investments

Trovo HealthReveleerDispatchHealthCurana HealthMarathon HealthUnified Women's HealthcareRialticAkidoArtis BioSolutionsAugust Bioservices

Board Seats

Career Timeline

null
Began his career at Alex. Brown & Sons.
2014
Co-founded Oak HC/FT to invest exclusively in healthcare and fintech companies.
2024
Joined the board of Trovo Health as Oak HC/FT led its $15 million seed round.
2024
Was named one of GrowthCap's Top 25 Healthcare Investors of 2024.

Sources & References

Oak HC/FT - Andrew Adams ↗Oak HC/FT - Team ↗Business Wire - Trovo Health Announces $15 Million Seed Funding Round Led by Oak HC/FT (April 30, 2024) ↗Reveleer - Andrew W. Adams board bio ↗